Inferring Numbers of Wild Poliovirus Excretors Using Quantitative Environmental Surveillance
Authors:
- Yuri PerepliotchikovYPYuri Perepliotchikov
- Tomer Ziv-BaranTZTomer Ziv-Baran
- Musa HindiyehMHMusa Hindiyeh
- Yossi ManorYMYossi Manor
- Danit SoferDSDanit Sofer
- Jacob Moran-GiladJMJacob Moran-Gilad
- Laura StephensLSLaura Stephens
- Ella MendelsonEMElla Mendelson
- Merav WeilMWMerav Weil
- Ravit BassalRBRavit Bassal
- Emilia AnisEAEmilia Anis
- Shepherd Roee SingerSSShepherd Roee Singer
Open Access
Abstract
Response to and monitoring of viral outbreaks can be efficiently focused when rapid, quantitative, kinetic information provides the location and the number of infected individuals. Environmental surveillance traditionally provides information on location of populations with contagious, infected individuals since infectious poliovirus is excreted whether infections are asymptomatic or symptomatic. Here, we describe development of rapid (1 week turnaround time, TAT), quantitative RT-PCR of poliovirus RNA extracted directly from concentrated environmental surveillance samples to infer the number of infected individuals excreting poliovirus. The quantitation method was validated using data from vaccination with bivalent oral polio vaccine (bOPV). The method was then applied to infer the weekly number of excreters in a large, sustained, asymptomatic outbreak of wild type 1 poliovirus in Israel (2013) in a population where >90% of the individuals received three doses of inactivated polio vaccine (IPV). Evidence-based intervention strategies were based on the short TAT for direct quantitative detection. Furthermore, a TAT shorter than the duration of poliovirus excretion allowed resampling of infected individuals. Finally, the method documented absence of infections after successful intervention of the asymptomatic outbreak. The methodologies described here can be applied to outbreaks of other excreted viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), where there are (1) significant numbers of asymptomatic infections; (2) long incubation times during which infectious virus is excreted; and (3) limited resources, facilities, and manpower that restrict the number of individuals who can be tested and re-tested.Keywords
Funding Information
- World Health Organization (Grant 18- TSA- 032)
This publication has 48 references indexed in Scilit:
- Feasibility of Quantitative Environmental Surveillance in Poliovirus Eradication StrategiesApplied and Environmental Microbiology, 2012
- From Emergence to Eradication: The Epidemiology of Poliomyelitis DeconstructedAmerican Journal of Epidemiology, 2010
- Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in IsraelVaccine, 2008
- Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune PopulationsPLOS ONE, 2006
- Multiplex PCR Method for Identifying Recombinant Vaccine-Related PoliovirusesJournal of Clinical Microbiology, 2004
- Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection1 1The authors thank Man-yee Yung, Sara Fung, Dr. Bonnie Kwan, and Dr. Thomas Li for their help in retrieving patient information.Gastroenterology, 2003
- Polio eradication: the OPV paradoxReviews in Medical Virology, 2003
- Duration of Poliovirus Excretion and Its Implications for Acute Flaccid Paralysis Surveillance: A Review of the LiteratureThe Journal of Infectious Diseases, 1997
- Immunofluorescence technique for the identification of poliovirusesThe Lancet, 1992
- The Confirmation and Maintenance of Smallpox EradicationNew England Journal of Medicine, 1980